After years of telling visitors to Brisbane what an awesome place it is for fun* adventures, I've decided to make a list in the order I remember them of my favourite places to go for ease of reference. Here goes ...
(*definition of fun may vary)
Our paper refuting earlier claim of SARS-CoV-2 genomic integration is now online
@CellReports
The virus does not enter human DNA
The same would be true of COVID-19 mRNA vaccines
Particular thanks to
@UQ_SCMB
authors for SARS-CoV-2 experiments
@UQ_News
Recent
@CellCellPress
study claiming HERVK transcription drives senescence has a fundamental RNA-seq analysis problem. The results don't show HERVK elements with intact Env are derepressed, nor are they differentially expressed in senescent cells. 🧵 1/n
Our manuscript reporting long-read
@nanopore
sequencing of SARS-CoV-2 infected HEK293T cells is now available as a preprint. It is work we did with some reluctance but given the context of the global pandemic it seemed obligatory.
I have posted this Contradictory Results to bioRxiv:
Re-analyzing RNA-seq data from this Neuron paper, I found the claimed L1 upregulation in ataxia telangiectasia (AT) cerebellum is due to an apparent RNA-seq batch effect. 1/n
The transposable elements (TEs) field has a steep literature learning curve and it's easy to miss key work (for me too).
Kazazian's 2004 Science piece got me into the world of TEs.
Here's a few of my favourites from the field over the last 5 years ...
Long-read
@nanopore
ONT sequencing 👇has lately changed my scientific life. It is an unprecedented tool to study retrotransposons (mobile DNA) and how they are regulated. Here's some examples to show what I mean: 🧵1/n
Preprint claiming SARS-CoV-2 integration by L1 RT into human cells has now been contributed to PNAS.
The authors have added ONT sequencing data and find an example of a potential SARS-CoV-2 integrant on chrX. Some thoughts about this: 1/n
Deniz et al (Nat Commun, 2020) is one of the best papers to come out of the TE field in recent years, and an (unusual?) example of work that looks even better when examined closely. It shows how endogenous retrovirus (ERVs) enhance oncogenes in AML. 1/n
Our study using
@nanopore
ONT sequencing to survey transposable element (TE) insertions and methylation landscapes in human tissues is now in print
@MolecularCell
. Detailed thread 👇
Open access link:
Work funded by
@nhmrc
@CSL
@materfoundation
1/n
For analysing retrotransposon expression using RNA-seq I would recommend TEtranscripts from
@MollyHammell
. The results are very similar to what I get using my own in house scripts but there is a maintained GitHub and it works well.
Is L1 retrotransposon activity in the brain specific to only some neuronal lineages? Check out our new preprint👇where we find L1 is activated by the SOX6 transcriptional program of parvalbumin (PV) GABAergic interneuron development. 1/n
Our new story on L1 repression by YY1 in humans is out at
@MolecularCell
. Young L1 families need to escape YY1-mediated methylation to jump, including in brain. L1 also needs YY1 to make full-length, mobile progeny. Relationship maybe maintained for >70Myr
Recent
@NatureGenet
study uses Illumina sequencing to call ~50K mobile element variants (MEVs) in ~3,700 Genomes from 1000GP and BioBank Japan cohorts, then uses these for GWAS and other genome-wide analyses. I have two major criticisms: 1/n
Postdoc advertised in my lab to study mobile DNA in mammalian genomes. Permanent position with superannuation and tax concessions in addition to advertised salary. Would suit someone straight out of PhD or a more experienced staff scientist.
Please RT
A Nature family journal that I think deserves praise for most of the transposable element (TE), or TE-related, work they have been publishing over the last year is
@NatureComms
. Here's a few of my favourites, in no particular order: 1/n
Important
@Nature
study today showing ERV envelope (Env) protein expression is at least predictive of outcome for lung adenocarcinoma (LUAD), and appears to influence improved response to therapy. 1/n
My pick for "the" mobile DNA paper of 2023 is actually two studies published back-to-back
@Nature
reporting the long-sought structure of L1 ORF2p _and_ fundamental insights into the mechanism by which L1 jumps. Amazing work. 1/n
Excellent paper out today in Nature from
@GenomeDoctor
reporting somatic retrotransposition in normal cells - mainly colon - and tumours. The analyses are rigorous, and say much about L1 mobility (and a bit of Alu) during early human development. 1/2
Very recent
@NatureGenet
study on methylation-restricted TF binding to genes and IAP retrotransposons. This got my attention: in vitro, DNMT TKO neurons expressed 268x more IAP than WT neurons, which had almost no IAP transcripts, measured by RNA-seq. 1/n
Interesting preprint from Ecker and Ren labs using single-cell multiomics to call candidate cis-regulatory elements (cCRE), including in transposable elements (TEs), in human, macaque, marmoset and mouse cortex. A few ideas for potential improvements: 1/n
Major update to our Nanopore-DamID preprint by
@SethCheetham
@YohaannJafrani
: we simultaneously surveyed CTCF binding and DNA methylation on single molecules, using a DamN126A mutant in HEK293T cells. CTCF clearly binds unmethylated alleles, eg XIST 👇 1/3
Review written with
@tashjansz
published today
@GenomeBiology
. We dissect the role(s) endogenous retroviruses and other TEs play in cancer, and their therapeutic potential. Some amazing work being done in this space but need improved resolution on TEs
Preprint from
@geochurch
lab is interesting.
#crispr
editing thousands of L1 sites without killing human cells. We have tried this in mice repeatedly (adding STOP to mobile L1s) to assess neuro phenotype and failed to get live young. Could be very useful!
Grateful to receive an
@nhmrc
Investigator Grant (L2). Thank you to the staff and students in my lab who made this possible, and to the reviewers for taking the time to write some nice comments. We'll make the most of the opportunity!
List of awardees 👇
My re-analysis of the Takahashi et al L1-drives-AT study has now been published as a Letter by
@NeuroCellPress
, along with a reply from the authors. I hope this is useful, particularly to anyone considering strategies to treat AT in the future. 1/n
@nhmrc
urgent now to implement equal funding success rates for male and female Ideas and Investigator Grant applicants, starting with the open Ideas Grants round. Women will be unequally affected by COVID-19 shutdown, now is the time to guarantee a fair go to all applicants. 1/2
Our new study surveying the acquired mutational landscape of mouse induced pluripotent stem cells (iPSCs) is now a preprint. Work led by
@Patricia_Grds
and Sue Mei Lim. Collaboration with Jose Polo lab and
@_adamewing
@RichardsonL1Lab
@ry_lister
1/n
Recent study claims repeat transcript abundance in cell-free RNA (cfRNA) from plasma can discriminate pancreatic cancer vs normal samples. I have some concerns about apparent RNA quality differences between the two groups: 1/n
I should add we have more deeply ONT sequenced (53x, 40kbp N50) HEK293T cells infected with SARS-CoV-2, at a higher MOI than this study, and found absolutely no alignments to the relevant SARS-CoV-2 isolate genome using minimap2. Nothing. 5/n
Four papers from my lab published over the past year looking at DNA methylation applied to young L1 retrotransposons in somatic tissues (inc. cancer), early embryo and neurodiff: 1/n
Very interesting preprint reporting 1250 somatic L1 insertions detected with WGS of ~900 single-cell clones, mostly from human epithelium and fibroblasts. The core dataset looks robust (pending supplement availability) and allowed source L1 tracing. 1/n
Elegant and careful experiments from the Moran and Miyoshi labs showing, amongst other things, that L1 RNA expression - and not cDNA - triggers an interferon response.
See Fig. 2F below: no difference in IFN-a for WT vs RT- L1 reporter expression.
Whether L1 has global insertion site preference is something that I struggle to assign a neat answer to. One of the most interesting findings in this recent comprehensive L1 pan cancer study is a enrichment for somatic L1 insertions in open chromatin. 1/n
Yesterday's Nature paper on somatic L1 retrotransposition in colon tells us more about the chr13q12.3 source L1 we have been studying for years in the brain: 1/n
Postdoc vacancy in my lab in sunny Brisbane - please RT.
You will have or soon have a PhD on mobile DNA or a closely related topic. 3+ years to work together on anything we both find interesting. Start within the next year. Overseas applications welcome.
Some quick thoughts on a "best practice" approach to find and measure transcripts with potential to express HERVK proteins: 1/n
(not saying this is the only way - please comment)
Our latest preprint applies
@_adamewing
's new TLDR software, for retrotransposon mapping and methylation analysis using Oxford
@nanopore
long read sequencing, to a set of human tissues. Wonderful tech.
@SethCheetham
Editorial from our Guest Editor
@Faulkner_Lab
introducing our latest special issue on the genomics of regulatory elements. The editorial highlights the first tranche of publications in the issue, which can be found here:
Interesting recent paper
@NatureComms
showing LTR5_Hs (HERVK) act as regulatory elements in human primordial germ cells (and hPGC-like cells). Had a close look (signed review) and it is well done. Demethylation on LTR5_Hs in PGCs is surprisingly strong.
Preprint from
@JakobssonLab
characterising L1 retrotransposon transcripts in human brain. Includes some important data for the field and the lncRNA phenotype in brain organoids is intriguing. I had a few thoughts about the L1 sense transcript data: 1/n
Recent Genome Res paper from Jorde lab estimating heritable retrotransposition rate in human pedigrees is rigorous and worth reading. Nearly 600 people across 3 generations analysed with 30x WGS to find de novo L1, Alu and SVA insertions in offspring. 1/n
Hard to see so many people scored as excellent or outstanding missing out on Investigator Grants. Since 2009,
@nhmrc
funding has increased at annual indexation of ~1.5%, versus inflation of ~2.1%. In real terms, NHMRC budget has decreased 7% over the last decade 1/n
Read this
@Nature
paper with great interest. It concluded profound/severe de-repression of TEs in Polycomb/Ezh2 conditional knock out (CKO) female primordial germ cells (PGCs):
I downloaded and re-analyzed the RNA-seq data and this is what I found: 1/n
Interesting preprint dissecting how DNA methylation and HUSH together repress human L1 retrotransposon transcription. Very surprising that HUSH (and H3K9me3) depletion in hNPCs has no impact on L1 transcription. I had a few thoughts about this work: 1/n
Study from Devine lab just published
@genomeresearch
. Reports >100K TE polymorphisms in nearly 58K individual genomes. Use of PacBio long reads to resolve internal sequences of ~650 full-length L1HS elements (in one study!). A wonderful resource. 👏👏
Had fun previewing
@MolecularCell
Article from
@torbenheick
showing convincingly that NEXT works with HUSH to limit retrotransposon RNA expression.
Article here:
Preview here:
(Cartoon credit to Lizzy Haines and
@eugeniaferreiro
)
Preprint shows Cas9 to enrich
@nanopore
reads for human TEs in GM12878, very nice!
-Might be used to profile TE family 5mC
-Fair to note TE calling with ONT done by us (Ewing Mol Cell 2020)
-Enrichment (L1HS vs L1PA2/L1PA3) may be tricky to calculate
Very recent
@genomeresearch
functional genomics study of ERV enhancers in human trophoblast cells reveals new TF/ERV binding combinations (beyond e.g. STAT1/MER41) that appear to regulate genes essential to placenta development.
1/n
Welcome to the lab
@charles_bell92
! Charlie is interested in the transcriptional regulation of transposable elements, and is joining us after his PhD and first postdoc with
@MAF_Dawson
.
Paper in
@NatureGenet
showing L1 repression by MPP8 and a broader tumour suppressive function for L1 retrotransposition in AML is interesting but leaves me with some initial doubts about the endogenous L1HS analyses ... open to explanations 1/n
Congrats to the decrypTEd team, short listed by
@CancerGrand
for the Retrotransposable elements challenge:
The decrypTEd team is outstanding and the concept is very well thought out, would be great to see them succeed at the next stage.
A couple of papers that would be worth referring to here. Firstly, this excellent review from
@sophie_lanciano
and
@retrogenomics
explains the objectives and pitfalls of RNA-seq analyses of TEs: 15/n
Study published late 2019 in Nat Ecol Evol maps pachytene piRNA loci in humans. Fascinating that in humans (and mice: Aravin et al.) there are two waves of piRNA production. Early fetal piRNAs -> transposons, postnatal piRNAs -> non-transposons 1/n
I'll be speaking about our work on mobile DNA and escapee L1 retrotransposons at:
JCBC (Uni Cambridge) 1pm April 12, Paul Lehner host
IDRM (Uni Oxford) noon April 15,
@RBerrens
host
ICTE conference (St Malo) 4pm April 21
I've been promised it'll be warm and sunny throughout :)
L1 retrotransposition in ovarian carcinoma paper just published
@CellReports
@Carreira_DrP
#transposons
. Main finding is that L1 mutations are heterogeneous in tumour cells and profile can change after chemo 1/n
Fascinating preprint from
@JonasKoeppel
et al uses prime editing to insert loxP sites into hundreds of human L1 copies, make a bit of a genetic mess, and then see how the genome evolves in vitro. Looks well done from a design and analysis standpoint too.
Preprint using HiC to resolve protein-DNA binding profiles of very young mammalian TE insertions is fantastic. Solves the "multi-map" problem quite well, using L1HS and MERVL for examples in human and mouse. 1/n
@DarrenT243
@retrogenomics
@BrancoLab
@HardSciFiMovies
@TheAlexKnapp
@nanopore
Reluctance because it was a deviation from what I want to work on. Obligatory because it's an area of potential public health concern and we (with crucial collaborator involvement) had the expertise and capacity to ask whether we could verify the original findings.
We did not overexpress the L1 RT, as HEK293T cells already provide a very friendly environment for L1 mobility, one that is unlikely to be encountered by the virus in vivo. Adding the L1 RT makes it even more artificial. I suppose we had better get that data out now. 6/6
Congratulations to my now former postdoc Sandy Richardson
@SandyRtsn
for her well deserved promotion to Academic Level C (Senior Research Fellow / Group Leader) by the University of Queensland. Going to do great things Sandy!
Preprint with
@AnjanaRaoLab
@SAMyers_lab
dissects OGT-TET interaction. OGT mutation reduces mC, increases hmC, and increases retrotransposon expression. WGBS, ONT
@nanopore
and six-letter sequencing
@biomodalhq
methylomes from control and OGT iKO mESCs.
The best news I have heard in ages: senior lab postdoc Sandy Richardson
@birdofparadox22
being awarded an
@nhmrc
EL1 grant. Sandy is the person whose ideas most often make me think "I wish I had thought of that, I wish I was that clever". Well deserved Sandy.
#transposons
Pointing here to the response from Dr Liu which isn't as visible being further down in this thread. Thank you for providing this
@ZunpengLiu
. It clarifies some of the experimental design and presents heatmaps representing individual HERVK loci. As promised I expanded my analysis:
@Faulkner_Lab
@CellCellPress
We sincerely thank Dr. Faulkner
@Faulkner_Lab
for all these useful comments and discussions. Please see our full responses in the attachment.
Figures can be found here:
Thanks a lot!
Catching up on reading: this excellent study from
@LabRowe
really highlights how interconnected transposable element (TE) and gene regulatory mechanisms are:
1/n
Article from my lab out at
@GenomeBiology
expanding the repertoire of pseudogene transcripts with PacBio long read sequencing. Some spectacular transcripts spanning TEs, pseudogenes and genes here! Esp credit to
@SethCheetham
@_adamewing
@robinleetroskie
Two
@nature
papers over the past couple of months have reported m6A regulation of transposable element (TE) expression in mESCs. These are really interesting studies but, to me at least, seem to make opposing findings regarding m6A applied to young L1s. 1/n
Some beautiful analysis in this paper, tells us a lot about L1 transcription and the regulatory relationships between L1 insertions and the loci they inhabit.
Peer review ramblings
#1
: while there are many wonderful CNS papers, the quality of science done in the field-specific journals a tier or two below CNS is no lower than CNS. The divide between the claims made and the data in support is however often smaller.
Welcoming recently started NHMRC Emerging Leadership Fellow
@tashjansz
to the lab. Lots of fun mobile DNA and epigenomics projects to be had in the years to come!
Speaking of which, it's been about 3 years (~150 manuscripts) now of signing my referee reports and I can't say I've noticed any real drawbacks of doing so. Here are some things I've noticed: 1/n
A few months back I started signing my journal referee reports. Various reasons for this. One positive I have discovered is that if I then supply a supportive but also critical review of a manuscript to a journal where it is rejected, the authors can address my critiques 1/n
Pre-print claiming reverse transcription of SARS-CoV-2 RNA does not show this.
Where is the evidence for TPRT? Where is the insertion sequencing to find TSDs? qPCR to measure genomic integration of an RNA is about the lowest standard I could think of.
Last day of
#AusEpi22
. Fun and well run conference in a great location. Lots of interesting work and good science chat too. Thanks
@AEpiA
(and saw whales migrating by at sunrise this morning).
A few months back I started signing my journal referee reports. Various reasons for this. One positive I have discovered is that if I then supply a supportive but also critical review of a manuscript to a journal where it is rejected, the authors can address my critiques 1/n
Paper in
@genomeresearch
evaluates how polymorphic Alu insertions modulate gene expression. V. interesting long-range Alu eQTLs found for breast cancer loci, including MYC, confirmed by CRISPR. Excellent work and congrats to the authors
@KathleenHBurns
Paper out today
@NatureGenet
used CRISPR-Cas9 to delete DNMT and TET genes in human embryonic stem cells (hESCs) and then performed whole genome bisulfite sequencing (WGBS) to assess the impacts of these deletions upon the epigenome. Generally I thought this was well done. 1/n
Terrific work showing how sequence variation in IAP retrotransposons can cause them to escape TRIM28 silencing in embryonic and neural progenitor cells. Also complements what we and others have done recently on L1 retrotransposon escapees in somatic cells. Bravo!
Excited this is out in
@CellReports
: Rocio Enriquez-Gasca &
@DrPoppyGould
shed light on how endogenous retroviruses gain beneficial roles in development & immunity, and why retrotransposons can jump in cancers, once epigenetic regulation is compromised:
Contributed to this Voices piece for the recent
@MolecularCell
special issue on the Central Dogma, and focused on the reverse transcriptase (RT) encoded by the L1 retrotransposon protein ORF2p.
"What, if anything, does the ORF2p RT do in somatic cells?"
@Nature
study dissecting HUSH repression of L1 retrotransposons is my favourite mobile DNA paper of 2022. Tough decision ... this was the "one" for me due to design, execution and importance. And
@seczynska
answered questions convincingly. Great stuff!
Recent and very interesting
@PNASNews
study shows R2 retrotransposons help to maintain rDNA repeat copy number in the fly germline. R2 has told us a lot about retrotransposition (eg Eickbush's 1993 Cell paper on TPRT). I have some questions though:
1/n
To make it a bit clearer what I mean about the chr22 example from Zhang et al., I did a diagram of the ONT read to show its composition. Keep in mind that this is crucial to support the findings. It looks like some sort of artifact ... never seen an L1-mediated event like it.
The RNA-seq seems to have been via rRNA depletion, and featureCounts QC suggests ~35% of the reads align to introns. I (+others) have in the past noted the dramatic impact on transposable element (TE) quantitation these intronic reads can have. 9/n
Finally got around to reading the newer mouse part of the Alu tail-loss paper () from
@BoXia7
@ItaiYanai
@JefBoeke
. I know this story stirred up a lively debate but it all seems reasonably put to me and quite thoughtful when it comes to caveats ... 1/2
Another reproducibility thread: the methylation data in the SPOCD1 KO O'Carroll lab Nature paper (Zoch et al.) are really impressive on closer examination, and if anything the paper understates the impact SPOCD1 and MIWI2 KO have on L1 methylation. 1/n
Congrats
@Patricia_Grds
and
@RichardsonL1Lab
! This study tells us a lot about mouse L1 methylation dynamics during development. The
@nanopore
data in Fig 4 shows an incredible sawtooth 5mC profile on the mouse L1 5'UTR in mESCs. Interesting system of L1 truncation over time too.
🧬Excited to share that the 2nd story out of my PhD is now on bioRxiv!🧬We resolved locus-specific methylation dynamics of the monomeric mouse L1 promoter during development using bisulfite & nanopore sequencing! w/
@RichardsonL1Lab
@Faulkner_Lab
👇 1/6
Finally got time to look closely at preprint reporting a second HUSH complex, HUSH2, centred around the TASOR paralog TASOR2. Study does an excellent job of showing HUSH2 exists. Suggests there is competition between TASOR and TASOR2. A few thoughts: 1/n
Discussed this
@nature
paper on HUSH at our journal club. Very positive consensus ... important findings supported by well designed science. I wonder though about the prior Wysocka lab result showing an intron was less important than codon optimisation 1/n
I'm looking to hire a full-time Research Assistant for my team at Mater. A broad molecular biology skill set is a must. Happy to answer questions about the role on DM or email. Please RT.
New review led by senior postdoc Gabriela Bodea just out in
@RSocPublishing
Open Biology. Idea was to write it for
#neuroscience
people interested in
#transposon
activity in brain. Focus on L1 in neurodegeneration and case studies. Hope it's useful.
Paper published recently
@NatureSMB
focuses on nanopore methylome analyses of mouse transposable elements. Surprisingly, the FAST5 data files required to replicate the main findings, some of which are quite unexpected, are not available 1/n
@CytoChromaC